Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00462254 · ClinicalTrials.gov registry record · Phase 4
Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease
A Phase 4 study, sponsored by Southern California Institute for Research and Education.
- Terminated
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT00462254 is a Phase 4 study that was terminated before completion, run by Southern California Institute for Research and Education. The registered enrollment target is 4 participants.
The verdict
NCT00462254, a Phase 4 study, was terminated before completion, sponsored by Southern California Institute for Research and Education.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
Patients with Parkinson's disease represent a significant proportion of VA elderly patients. Sleep disturbances and caregiver burnout association with this condition represent a significant problem. In this study, the investigators propose to perform an evaluation of a fixed doe of ramelteon on sleep in VA outpatients diagnosed with Parkinson's disease. The hypothesis to be examined is that ramelteon will improve the quality of sleep in patients with Parkinson's disease while indirectly improving the quality of life for the patients and caregivers. The investigators further hypothesize that these changes will occur through restructuring and normalization of the sleep architecture.
Interventions
- DRUG Ramelteon
- DRUG ROZEREM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00462254
The ClinicalTrials.gov registry entry for NCT00462254 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southern California Institute for Research and Education, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ramelteon is the first listed.
NCT00462254 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00462254 about?
NCT00462254 is a clinical study titled "Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease". Patients with Parkinson's disease represent a significant proportion of VA elderly patients. Sleep disturbances and caregiver burnout association with this condition represent a significant problem. In this study, the investigators propose to perform an evaluation of a fixed doe of ramelteon on slee...
What is the current status of trial NCT00462254?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2007-06. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00462254?
The interventions under investigation include: Ramelteon (DRUG), ROZEREM (DRUG).
Who is sponsoring clinical trial NCT00462254?
This trial is sponsored by Southern California Institute for Research and Education, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.